mRNA Cancer Vaccine with Pembrolizumab Shows Remarkable Phase 3 Melanoma Recurrence Reduction
mRNA Cancer Vaccine with Pembrolizumab Shows Remarkable Phase 3 Melanoma Recurrence Reduction In a watershed moment for oncology, the combination of a personalized mRNA cancer vaccine and an immune…